News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Imugene.
RELATED STOCKHEAD STORIES
Explainers
The 100 best performing ASX stocks in FY21
Health & Biotech
ScoPo’s Powerplays: ‘Prepare for a big jump in July’ as tax-loss selling in healthcare continues
Health & Biotech
ScoPo’s Powerplays: The immune oncology space finally gets long overdue attention
Health & Biotech
Invion led a group of ASX cancer stocks up after promising news
News
Quadruple Shot: These 12 ASX stocks have outperformed Bitcoin by 15 times – gaining over 300pc in 2021
News
Hot Money Monday: Global Health leads the pack as biotech heat up
Experts
ScoPo’s Powerplays: Hearing tech, medical devices to ride out choppy market
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Imugene led a biotech buying frenzy on the ASX today
News
Market highlights and 5 ASX small caps to watch on Tuesday
News
Hot Money Monday: Red Hill runs hot, as iron ore markets run even hotter
Experts
ScoPo’s Powerplays: Health sector trades sideways but M&A plays coloured the week
Health & Biotech
Imugene shares up 6pc on after ‘milestone’ for cancer vaccine
News
Last Orders: Sixth straight day of gains for small caps
News
Weekly ASX Small Cap Wrap: Who’s passed the test this week?
Health & Biotech
Imugene gains 10pc on cancer vaccine progress; 3 other biotechs getting patents
Health & Biotech